Loading ....
Filter
Sort By
Peptide
Alomone Labs
Peptide
972 Result Found
Sort By : Price - Low to High
-
MRS2 Blocking Peptide
$297- Description : MRS2 Blocking P
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
SLC38A9 Blocking Peptide
$297- Description : SLC38A9 Blockin
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Na+/H+ Exchanger 5/NHE-5 Blocking Peptide
$297- Description : Na+/H+ Exchange
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Na+/H+ Exchanger 6/NHE-6 Blocking Peptide
$297- Description : Na+/H+ Exchange
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Na+/H+ Exchanger 7 (NHE7) (extracellular) Blocking Peptide
$297- Description : Na+/H+ Exchange
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
NCX2/SLC8A2 Blocking Peptide
$297- Description : NCX2/SLC8A2 Blo
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Orexin Receptor 2 Blocking Peptide
$297- Description : Orexin Receptor
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
kappa-Opioid Receptor/OPRK1 (extracellular) Blocking Peptide
$297- Description : kappa-Opioid Re
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
delta-Opioid Receptor/OPRD1 (extracellular) Blocking Peptide
$297- Description : delta-Opioid Re
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNJ1/Kir1.1 Blocking Peptide
$297- Description : KCNJ1/Kir1.1 Bl
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.2 mg/ml.
-
Kv1.3/KCNA3 Blocking Peptide
$297- Description : Kv1.3/KCNA3 Blo
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.2 mg/ml.
-
GIRK2/Kir3.2 Blocking Peptide
$297- Description : GIRK2/Kir3.2 Bl
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.2 mg/ml.
-
Kv1.2/KCNA2 Blocking Peptide
$297- Description : Kv1.2/KCNA2 Blo
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.2 mg/ml.
-
KCNH2/erg1 Blocking Peptide
$297- Description : KCNH2/erg1 Bloc
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNMA1/KCa1.1 (1097-1196) Blocking Peptide
$297- Description : KCNMA1/KCa1.1 (
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.2 mg/ml.
-
KCNJ5/Kir3.4 Blocking Peptide
$297- Description : KCNJ5/Kir3.4 Bl
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
slobeta2/KCNMB2 Blocking Peptide
$297- Description : slobeta2/KCNMB2
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNK5/TASK-2 Blocking Peptide
$297- Description : KCNK5/TASK-2 Bl
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNK9/TASK-3 (extracellular) Blocking Peptide
$297- Description : KCNK9/TASK-3 (e
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
CNGA2 Blocking Peptide
$297- Description : CNGA2 Blocking
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
HCN4 Blocking Peptide
$297- Description : HCN4 Blocking P
- Reconstitution : 100 ul PBS
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 1.5 mg/ml.
-
KCNK10/TREK-2 Blocking Peptide
$297- Description : KCNK10/TREK-2 B
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
CNGA4 Blocking Peptide
$297- Description : CNGA4 Blocking
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Kv2.2/KCNB2 Blocking Peptide
$297- Description : Kv2.2/KCNB2 Blo
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Kir5.1 Blocking Peptide
$297- Description : Kir5.1 Blocking
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNS1/Kv9.1 (extracellular) Blocking Peptide
$297- Description : KCNS1/Kv9.1 (ex
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNF1/Kv5.1 Blocking Peptide
$297- Description : KCNF1/Kv5.1 Blo
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Kv6.4 (KCNG4) Blocking Peptide
$297- Description : Kv6.4 (KCNG4) B
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KChIP1/KCNIP1 Blocking Peptide
$297- Description : KChIP1/KCNIP1 B
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KChIP3/CSEN Blocking Peptide
$297- Description : KChIP3/CSEN Blo
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNMA1/KCa1.1 (extracellular) Blocking Peptide
$297- Description : KCNMA1/KCa1.1 (
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNQ5 Blocking Peptide
$297- Description : KCNQ5 Blocking
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNK15/TASK-5 (extracellular) Blocking Peptide
$297- Description : KCNK15/TASK-5 (
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
KCNQ4 Blocking Peptide
$297- Description : KCNQ4 Blocking
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Kir4.1/KCNJ10 (extracellular) Blocking Peptide
$297- Description : Kir4.1/KCNJ10 (
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
P2Y12 Receptor Blocking Peptide
$297- Description : P2Y12 Receptor
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Human P2Y11 Receptor Blocking Peptide
$297- Description : Human P2Y11 Rec
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
P2Y12 Receptor (extracellular) Blocking Peptide
$297- Description : P2Y12 Receptor
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
PAR1 (F2R) (extracellular) Blocking Peptide
$297- Description : PAR1 (F2R) (ext
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
LRRC8A (extracellular) Blocking Peptide
$297- Description : LRRC8A (extrace
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : Q8IWT6
- Concentration : 0.4 mg/ml.
-
Adenosine A2A Receptor Blocking Peptide
$297- Description : Adenosine A2A R
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Renin Receptor/ATP6AP2 (extracellular) Blocking Peptide
$297- Description : Renin Receptor/
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
alpha1A-Adrenergic Receptor (extracellular) Blocking Peptide
$297- Description : alpha1A-Adrener
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
beta2-Adrenergic Receptor (extracellular) Blocking Peptide
$297- Description : beta2-Adrenergi
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
alpha1D-Adrenergic Receptor (extracellular) Blocking Peptide
$297- Description : alpha1D-Adrener
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
alpha2A-Adrenergic Receptor (extracellular) Blocking Peptide
$297- Description : alpha2A-Adrener
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
alpha2C-Adrenergic Receptor (extracellular) Blocking Peptide
$297- Description : alpha2C-Adrener
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
C5aR2 (extracellular) Blocking Peptide
$297- Description : C5aR2 (extracel
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Adenosine A3 Receptor (extracellular) Blocking Peptide
$297- Description : Adenosine A3 Re
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
-
Bestrophin-2 (extracellular) Blocking Peptide
$297- Description : Bestrophin-2 (e
- Reconstitution : 100 ul double d
- Formulation : Lyophilized Pow
- Accession Number : BLP
- Concentration : 0.4 mg/ml.
ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.
© 2025 Biohippo. All rights reserved.